Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Bonneterre J, Mercier M, for the French Epirubicin Study Group: Response to chemotherapy after relapse in patients with or without previous adjuvant chemotherapy for breast cancer. Cancer Treat Rev 19(Suppl B): 21–30, 1993
2. Falkson G, Gelman G, Falkson CI et al.: Factors predicting response, time to treatment failure, and survival in women with metastatic breast cancer treated with DAVTH: a prospective Eastern Cooperative Oncology Group study. J Clin Oncol 9: 2156–2161, 1991
3. Valagussa P, Brambilla C, Zambetti M: Salvage treatments in relapsing resectable breast cancer. Recent Res Cancer Res 115: 69–76, 1989
4. Tannock I, Boyd N, DeBoer G et al.: A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6: 1377, 1988
5. Bastholt L, Dalmark M, Gjedde SB et al.: Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative Group. J Clin Oncol 14: 1146, 1990
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献